Neurofibromas
Showing 1 - 25 of 102
(PRO) Measures for Individuals With Neurofibromatosis 1 and
Recruiting
- Neurofibromatosis 1
- Plexiform Neurofibromas
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Neurofibromatosis 1 Trial in Boston (Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser)
Not yet recruiting
- Neurofibromatosis 1
- Deoxycholic Acid
- +3 more
-
Boston, MassachusettsWellman Center for Photomedicine
Nov 13, 2023
Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)
Active, not recruiting
- Neurofibromatosis 1 (NF1)
- Plexiform Neurofibromas (PN)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Cutaneous Neurofibromas in People With NF1
Recruiting
- Neurofibromatosis Type 1
- +3 more
- Evaluation of the natural history of cutaneous neurofibromas
-
Baltimore, MarylandJohns Hopkins University
Oct 12, 2022
Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Completed
- Neurofibromatosis Type 1
- Neurofibroma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group
Not yet recruiting
- Neurofibromatosis 1
- +2 more
- Test group (Group A): FCN-159 8 mg, orally, once daily;
- Control group (Group B): Placebo, orally, once daily;
- (no location specified)
Jun 16, 2023
Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)
Recruiting
- Neurofibromatosis 1
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
US Selumetinib Registry
Not yet recruiting
- Neurofibromatosis Type 1
- Plexiform Neurofibromas
- (no location specified)
Jan 5, 2023
Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)
Active, not recruiting
- Neurofibromatosis 1
- Neurofibroma Plexiform
-
Shanghai, China
- +1 more
Jan 13, 2023
Cutaneous Neurofibroma Trial in Boston (Kybella, 980nm laser, 755nm Alexandrite Laser)
Recruiting
- Cutaneous Neurofibroma
- Kybella
- +3 more
-
Boston, MassachusettsWellman Center for Photomedicine, Massachusetts General Hospital
Aug 10, 2022
Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)
Not yet recruiting
- Neurofibroma
- Neurofibroma, Plexiform
- Cryotherapy
- (no location specified)
Jan 19, 2022
Cutaneous Neurofibroma Trial in New York (DPCP)
Not yet recruiting
- Cutaneous Neurofibroma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 24, 2022
Neurofibromatosis 1 Trial in Baltimore, Redwood City
Recruiting
- Neurofibromatosis 1
-
Baltimore, California
- +1 more
Aug 17, 2022
Neurofibromatosis 1, Plexiform Neurofibromas Trial in Shanghai (HL-085)
Recruiting
- Neurofibromatosis 1
- Plexiform Neurofibromas
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital, Shanghai JiaoTong University S
Apr 10, 2022
Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)
Completed
- Neurofibromatosis
- MPNST
- MRI, FDG-PET/CT scans
- [18F]-FLT-PET/CT scans
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Cutaneous Neurofibroma Trial in Copenhagen, Gothenburg (TOOsonix System ONE-M)
Active, not recruiting
- Cutaneous Neurofibroma
- TOOsonix System ONE-M
-
Copenhagen, Hovedstaden, Denmark
- +1 more
Jun 23, 2022
Malignant Peripheral Nerve Sheath Tumor Development in
Active, not recruiting
- Neurofibromatosis 1
- Peripheral Nerve Neoplasms, Malignant
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
NEUROFIBROMATOSIS 1 Trial in Milwaukee (aminolevulinic acid)
Recruiting
- NEUROFIBROMATOSIS 1
- aminolevulinic acid
-
Milwaukee, WisconsinThe Medical College of Wisconsin
Nov 30, 2021
Neurofibromatosis Type 1 Trial in Worldwide (Selumetinib)
Active, not recruiting
- Neurofibromatosis Type 1
-
Rochester, Minnesota
- +8 more
Nov 10, 2022
Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)
Active, not recruiting
- Neurofibromatosis 1
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Neurofibromatosis Type 1, Plexiform Neurofibromas, Post-operative Trial in Beijing, Shanghai (Selumetinib, Placebo)
Not yet recruiting
- Neurofibromatosis Type 1
- +2 more
- Selumetinib
- Placebo
-
Beijing, China
- +2 more
Apr 11, 2023
Frameshift Peptides of Children With NF1
Completed
- Neurofibromatosis Type 1
- Frameshift Array blood sample test
-
Washington, District of Columbia
- +2 more
Aug 29, 2022
Cutaneous Neurofibroma, Neurofibromatosis 1 Trial in United States (NFX-179 gel, Vehicle gel)
Recruiting
- Cutaneous Neurofibroma
- Neurofibromatosis 1
- NFX-179 gel
- Vehicle gel
-
Little Rock, Arkansas
- +22 more
Jan 18, 2023